Akeso Appoints Prof. Bradley Monk as Lead Gynecologic Oncology...
LOS ANGELES, June 24, 2020 /PRNewswire-AsiaNet/ -- -- To develop its registration trial of AK104 (Bi-specific Anti-PD1/CTLA-4 Antibody) in Cervical CancerAkeso, Inc. ("Akeso", 9926.HK) announced the appointment of Professor Bradley J. Monk, MD, FACOG[1], FACS[2] as Lead Gynecologic Oncology ...
Authors: LATEST ASIANET NEWS RELEASES